Focus: Virtuoso Surgical develops an endoscopic surgical robot platform focused on minimally invasive oncology procedures, particularly bladder lesion excision. The company is early-stage and pre-revenue, operating from Nashville, Tennessee.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Growing — net +18 jobs in 30d
19 jobs added vs 1 removed. Steady team buildout.
High-risk, high-reward early-stage medtech opportunity best suited for risk-tolerant professionals seeking deep equity exposure and operational control in surgical robotics.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Virtuoso Surgical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Virtuoso Surgical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles